CSI Market
Sign In | Register

Insmed Inc (INSM) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access INSM quarterly Cash Flow →
Reviewing cash flow figures over time highlights how Insmed Inc balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-1,276.78
Depreciation & amortization10.45
Amortization of Other Assets12.22
Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability251.99
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-31.52
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation152.71
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.00
Increase Decrease In Accrued Liabilities And Deferred Rent Credit-
Amortization Of Debt Discount Premium And Accretion Expense-
Finance Lease Right Of Use Asset Amortization2.71
Increase Decrease In Accrued Liabilities Accrued Compensation And Other Current Liabilities-
Increase Decrease In Accrued Liabilities Accrued Compensation And Other Current Liabilities-
Income taxes0.00
Unrealized Gain (Loss) on Derivatives0.00
Increase (Decrease) in Accounts Receivable-88.31
Increase (Decrease) in Accounts Payable and Accrued Liabilities100.07
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-53.43
Other Working Capital-7.12
Other Noncash Expense20.68
Other net0.00
Payments for (Proceeds from) Other Operating Activities-28.70
Discontinued operations0.00
Net Cash flow from Operating Activities-935.01
Investing Activities
Capital Expenditures-32.56
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities2,090.00
Payments to Acquire Marketable Securities-2,092.01
Real Estate Investments0.00
Proceeds From Cash Acquired In Asset Acquisition-
Payment Of Milestone-30.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-64.58
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-1.97
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock959.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Common Stock Conversion Of Warrants-
Payments For Proceeds From Financing Lease Tenant Allowance-
Finance Lease Principal Payments-2.96
Proceeds From Royalty Financing-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities954.07
Effect of exchange rate on cash flow0.93
Discontinued operations0.00
Free Cash Flow-967.58
Total Cash Flow-44.59
4 historic quarters locked

Sign in to unlock the full Insmed Inc cash flow history.

Sign In Create Free Account

About Insmed Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 19, 2026
  • Source: insm-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104506-26-000009

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License